![]() | |
Names | |
---|---|
IUPAC name (17S)-17-hydroxyoctadeca-9,11,13,15-tetraynoic acid | |
Identifiers | |
3D model (JSmol) | |
ChEBI | |
ChEMBL | |
ChemSpider | |
PubChem CID | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C18H20O3 | |
Molar mass | 284.355 g·mol−1 |
Appearance | grey-yellow needles [1] |
Melting point | 95 °C (203 °F; 368 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Minquartynoic acid is an unsaturated, conjugated, and hydroxylated fatty acid containing four triple bonds and belonging to the class of polyyne and alkynoic acids. It was only discovered in 1989. [2] The acid is optically active, but there are conflicting data regarding the rotation of the natural S-isomer. [3]
The acid was initially isolated by R.J. Marles, N.R. Farnsworth and D.A. Neill in 1989 from the stem of the Amazonian tree Minquartia guianensis . [4] [5]
The acid occurs only in small quantities in the bark or twigs of a few plant species, such as Minquartia guianensis , Ochanostachys amentacea , [6] and Coula edulis , [7] all of the family Olacaceae .
Minquartynoic acid can be synthesized starting from azelaic acid monomethyl ester in a seven-step synthesis. [8] Another synthesis of the compound has also been published. [9]
An infusion of the acid has been used by Ecuadorian indigenous people to treat intestinal parasitic infections, lung cancer, and tuberculosis; also, it has been applied topically to treat skin irritations and muscle pain. [10]
In in vitro studies, minquartynoic acid was antiviral against HIV and cytotoxic against ten different cancer cell lines, including leukemia cells. [11] [12] In other studies, it has shown activity against malaria and Leishmania. [3]